Recent advances in Chinese medicine for contrast-induced nephropathy

Xue-zhong Gong

doi:10.1007/s11655-017-2906-x

Your Location：

Home >

Browse articles >

Recent advances in Chinese medicine for contrast-induced nephropathy

Updated：2021-08-27

- Recent advances in Chinese medicine for contrast-induced nephropathy
- Chinese Journal of Integrative Medicine Vol. 24, Issue 1, Pages: 6-9(2018)
- Affiliations：
  
  Department of Nephrology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine,Shanghai,China
- Author bio：
- Funds：
  
  The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag Berlin Heidelberg 2017 Supported by the National Natural Science Foundation of China (No. 81573936 and 81373614), Shanghai Municipal Hospital Xinxing Qianyan Project (No. SHDC12015126), and Shanghai Pujiang Program (No. 15PJD036)
- DOI：10.1007/s11655-017-2906-x
  CLC：
- Published：2018，
  
  Published Online：6 October 2017，
Scan for full text
Gong, Xz. Recent advances in Chinese medicine for contrast-induced nephropathy., Chin. J. Integr. Med. 24, 6–9 (2018). https://doi.org/10.1007/s11655-017-2906-x

Xue-zhong Gong. Recent advances in Chinese medicine for contrast-induced nephropathy. [J]. Chinese Journal of Integrative Medicine 24(1):6-9(2018)
Gong, Xz. Recent advances in Chinese medicine for contrast-induced nephropathy., Chin. J. Integr. Med. 24, 6–9 (2018). https://doi.org/10.1007/s11655-017-2906-x DOI：

Xue-zhong Gong. Recent advances in Chinese medicine for contrast-induced nephropathy. [J]. Chinese Journal of Integrative Medicine 24(1):6-9(2018) DOI： 10.1007/s11655-017-2906-x.

摘要

Abstract

关键词

Keywords

references

Gong XZ, Duan YR, Zheng JL, Wang YR, Wang GH, Norgren S, et al. Nephroprotective effects of N-acetylcysteine amide against contrast-induced nephropathy through upregulating thioredoxin-1, inhibiting ASK1/p38MAPK pathway, and suppressing oxidative stress and apoptosis in rats. Oxid Med Cell Longev 2016;2016:8715185.

Gong XZ, Celsi G, Carlsson K, Norgren S, Chen M. N-acetylcysteine amide protects renal proximal tubular epithelial cells against iohexol-induced apoptosis by blocking p38 MAPK and iNOS signaling. Am J Nephrol 2010;31:178–188.

Geenen RW, Kingma HJ, van der Molen AJ. Contrastinduced nephropathy: pharmacology, pathophysiology and prevention. Insights Imaging 2013;4:811–820.

Abu Jawdeh BG, Leonard AC, Sharma Y, Katipally S, Shields AR, Alloway RR, et al. contrast-induced nephropathy in renal transplant recipients: a single center experience. Front Med (Lausanne) 2017;4:64.

Stacul F, van der Molen AJ, Reimer P, Webb JA, Thomsen HS, Morcos SK, et al. Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines. Eur Radiol 2011;12:2527–2541.

Chong E, Shen L, Poh KK, Tan HC. Risk scoring system for prediction of contrast-induced nephropathy in patients with pre-existing renal impairment undergoing percutaneous coronary intervention. Singapore Med J 2012;53:164–169.

Schilp J, de Blok C, Langelaan M, Spreeuwenberg P. Guideline adherence for identification and hydration of highrisk hospital patients for contrast-induced nephropathy. BMC Nephrol 2014;15:2.

Che ML, Yan YC, Zhang Y, Gu Y, Wang NS, Chen N, et al. Analysis of drug-induced acute renal failure in Shanghai. Natl Med J China (Chin) 2009;89:744–749.

Yuan Y, Qiu H, Hu X, Luo T, Gao X, Zhao X, et al. Predictive value of inflammatory factors on contrast-induced acute kidney injury in patients who underwent an emergency percutaneous coronary intervention. Clin Cardiol 2017; May 19. doi: 10.1002/clc.22722. [Epub ahead of print]

Gong XZ, Wang Q, Tang XC, Wang YR, Fu D, Lu HY, et al. Tetramethylpyrazine prevents contrast-induced nephropathy by inhibiting p38 MAPK and FoxO1 signaling pathways. Am J Nephrol 2013;37:199–207.

Gong XZ, Wang YR, Fu D, Tang XC, Wang YR, Wang GH, et al. Research on Radix et Rhizoma Rhei-Rhizoma Ligustici Chuanxiong restraining renal tubular epithelial cell apoptosis in contrast-induced nephropathy rats. Shanghai J Tradit Chin Med (Chin) 2013;47:69–71.

Gong XZ, Wang YR, Fu D, Tang XC, Wang YR, Wang GH, et al. Effects of Zhi Dahuang-Chuan Xiong drug pair on tubular epithelial cell apoptosis in contrast-induced nephropathy rats. Chin J Integr Tradit West Nephrol (Chin) 2012;13:675–677.

Gong XZ, Wang YR, Wang GH, Fu D, Wang Q, Tang XC, et al. TMP inhibited apoptosis of tubular epithelial cells in contrast-induced nephropathy rats. Beijing Med J (Chin) 2013;35:131–133.

Men WJ, Ding ZM. Effect of Uremic Granule on renal function and microinflammation in patients with chronic renal failure. Chin J Intern Med (Chin) 2016;33:201–202.

Wang XC, Liu CH, Wu C. Effects of colonic dialysis combined with Uremic Clearance Granule retention-enema on patients with chronic renal failure. J Pract Med (Chin) 2012;28:2528–2530.

Ding WF, Zhong AM, Wang JY, Song L, Chen H. Renal protective effects and mechanism of Uremic Clearance Granule on contrast-induced nephropathy. Chin J Integr Tradit West Nephrol (Chin) 2014;15:612–614.

Lian JP, Han S, Fang ZY, Li XC, Zuo Y. Effects of Shenkang Injection on chronic renal failure: a meta-analysis. Chin Tradit Patent Med (Chin) 2015;37:1677–1682.

Wang XD, Shen JP, Lou B. Observation on the effect of Shenkang Injection on preventing contrast-induced nephropathy after senile coronary heart disease interventional surgery. J Nanjing Univ Tradit Chin Med (Chin) 2013;29:426–428.

Zhang W. The clinical study of Danhong Injection combined with edaravone in the treatment of acute ischemic stroke. Chin J Prim Med Pharm (Chin) 2017;24:1050–1053.

Leng Q, Dai R, Liu YH. Influence of Danhong Injection on the microcirculation state related indexes of patients with myocardial infarction. J Clin Med Pract (Chin) 2017;23:6–8.

Liu JY, Li QH, Yin JF. Clinical efficacy and prevention of Danhong Injection in contrast-induced nephropathy (CIN) in patients with acute coronary syndrome undergoing percutaneous coronary intervention (PCI). Jilin Med (Chin) 2013;34:6474–6475.

Qi CX, Wu W, Zhu QM, Wang CC, Qin LJ, Xu YT. Systematic review and Meta-analysis of Danhong Injection combined with hydration in the prevention of contrast-induced nephropathy. Chin J Integr Med Cardio- Cerebrovasc Dis (Chin) 2017;15:570–573.

Zhao CX, Jin HX. Progress of pharmacological action mechanism and clinical application of salvianolic acid. Hebei Med (Chin) 2017;39:294–299.

Hua JY, Sun Q, Jiang XH, He YZ, Lv SM. Protective effect of salvianolate on contrast-induced nephropathy after coronary interventional therapy. Zhejiang Med (Chin) 2012;34:1883–1885.

Xu WY, Li P, Li ZX, Zhao YM, Wang ZD, Chen J. Effects of the alprostadil combined with salvianolate on renal function in patients who received PCI. Chin J Evid Based Cardiovasc Med (Chin) 2017;9:277–279.

Huang J, Yuan M, Ma J, Liu R, Dong Z, Zhao G, et al. Protective effects of salvianolate on contrast-induced nephropathy after primary percutaneous coronary intervention: a prospective multicenter randomized controlled trial. Cardiology 2017;138:169–178.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

No data

Related Author

No data

Related Institution

No data

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰